Clinical Guides
Coeliac Disease
A clinically focused clinical guide to recognizing, confirming and managing coeliac disease without undermining diagnosis through premature gluten withdrawal, with age-specific biopsy pathways, nutritional surveillance and practical Indian dietary safeguards.
MedNext Academy | 15 min read
Coeliac Disease
A clinically focused clinical guide to recognizing, confirming and managing coeliac disease without undermining diagnosis through premature gluten withdrawal, with age-specific biopsy pathways, nutritional surveillance and practical Indian dietary safeguards.
Summary
Coeliac disease is a chronic immune-mediated disorder caused by gluten exposure in genetically susceptible people. Gluten from wheat, barley and rye drives small-intestinal mucosal injury; presentations range from diarrhoea, steatorrhoea and faltering growth to iron-deficiency anaemia, fatigue, osteoporosis, aphthous ulcers, raised transaminases, neuropathy, infertility or no obvious symptoms. It is not an IgE-mediated wheat allergy, and symptom improvement after avoiding wheat does not by itself establish the diagnosis.
The central diagnostic safeguard is to test while the patient is eating gluten. First-line serology is immunoglobulin A tissue transglutaminase antibody, abbreviated tTG-IgA or TGA-IgA, together with total IgA. IgA deficiency requires an IgG-based pathway. A positive result prompts specialist confirmation; most adults and many children require well-sampled duodenal biopsy. A no-biopsy diagnosis is available only to selected children under a paediatric specialist protocol, not to every patient with a positive antibody.
Treatment is a strict lifelong gluten-free diet after confirmation, supported by a knowledgeable dietitian. Follow-up assesses symptoms, growth or weight, serology, deficiencies, bone health, adherence and inadvertent contamination. Persistent symptoms are more often caused by ongoing exposure or another disorder than true refractory disease. In India, wheat-rich diets, mixed household kitchens, loose flour, restaurant cross-contact, variable laboratory assays and unequal specialist access require explicit planning. This draft has been reviewed by the MedNext Clinical Team and is not a substitute for individual care.
How Common Is It?
Coeliac disease occurs worldwide, but prevalence varies with ancestry, gluten consumption, case-finding methods and the accuracy of serology and biopsy. Population estimates often cluster near one percent, yet a single global number should not be applied mechanically to every Indian region. Hospital cohorts over-represent symptomatic disease, seroprevalence is not identical to biopsy-confirmed prevalence, and changing wheat consumption can alter recognition over time. The clinically important message is that coeliac disease is common enough to test for when the indication is present and remains substantially underdiagnosed.
Indian disease burden is heterogeneous. Recognition has historically been strongest in northern wheat-consuming populations, but cases occur throughout India and migration makes geographic stereotypes unsafe. Rice-predominant residence does not exclude gluten exposure or genetic susceptibility. Delayed diagnosis may reflect attribution of anaemia to menstruation or nutrition, repeated empirical treatment of diarrhoea, cost of endoscopy, limited access to validated assays, or starting a gluten-free diet before assessment.
Higher-yield groups include first-degree relatives, people with type 1 diabetes or autoimmune thyroid disease, and those with selective IgA deficiency, Down syndrome or Turner syndrome. Testing is also warranted for persistent unexplained gastrointestinal symptoms, faltering growth, prolonged fatigue, weight loss, recurrent severe mouth ulcers, unexplained iron, folate or vitamin B12 deficiency, metabolic bone disease, persistently unexplained raised liver enzymes, selected neurological syndromes or otherwise unexplained subfertility. Risk remains a prompt to test, not a diagnosis. Negative testing may need reconsideration if symptoms evolve, gluten intake was inadequate or the initial test pathway was incomplete.
Risk Factors
HLA-DQ2 or HLA-DQ8 is necessary in almost all coeliac disease but is not sufficient: these alleles are far more common than the disease. A positive HLA result therefore has poor diagnostic specificity, whereas absence of the relevant alleles makes coeliac disease very unlikely and can help resolve selected specialist dilemmas. Routine HLA testing is not a first-line screen. Family clustering is clinically useful; first-degree relatives should be offered case-finding even when symptoms are subtle, with advice that a single negative result does not prevent later disease.
Autoimmune associations include type 1 diabetes and autoimmune thyroid disease. Selective IgA deficiency both increases coeliac risk and creates a diagnostic trap because an isolated tTG-IgA may be falsely negative. Down syndrome and Turner syndrome are recognized higher-risk settings. Dermatitis herpetiformis is a cutaneous manifestation of gluten-sensitive disease rather than a separate food allergy. Chronic unexplained iron deficiency, low bone density, growth failure and persistent transaminase elevation are presentation clues rather than causal risk factors.
Gluten exposure is required for the disease to become clinically and serologically apparent, but quantity, timing and individual susceptibility interact; families should not be blamed for causing the condition. Neither caesarean birth, a particular infant-feeding choice nor an isolated infection should be presented as a proven individual cause.
Iatrogenic diagnostic risk is important. Self-initiated restriction, advice from an unqualified practitioner, indiscriminate commercial food-intolerance panels and testing after weeks without gluten can produce uncertainty and years of unnecessary restriction. Conversely, dismissing symptoms because the patient is overweight, constipated, adult, southern Indian or lacks diarrhoea can delay diagnosis. Risk assessment should guide validated serology and specialist evaluation rather than unsupported elimination diets.
Diagnosis
Diagnosis combines a compatible clinical or risk context, coeliac-specific serology obtained during gluten exposure and, for most adults and many children, duodenal histology. Do not label disease from symptoms, HLA positivity or response to diet alone.
History
Ask gastrointestinal symptoms, stool character, distension, vomiting, constipation, weight trajectory, childhood growth, fatigue, oral ulcers, bone pain or fractures, rash, neurological symptoms, menstrual and reproductive history. Record autoimmune disease, IgA deficiency and first-degree relatives. Establish exactly how much gluten is currently eaten and whether restriction preceded testing. Current guidelines advises gluten in more than one meal daily for at least six weeks before testing when a normal diet has not been maintained; patients unable to reintroduce it need specialist planning rather than false reassurance.
Examination
Assess hydration, weight, BMI and serial height or growth centiles. Look for pallor, muscle wasting, oedema, aphthae, dental enamel defects, bruising, neuropathy or ataxia, and an intensely itchy extensor rash suggesting dermatitis herpetiformis. Abdominal findings are often nonspecific. Examine for another cause of bleeding or malnutrition when indicated.
Investigations
Request total IgA with tTG-IgA. Weakly positive adult results can be clarified with IgA endomysial antibody; when IgA is deficient use an appropriate IgG EMA, IgG DGP or IgG tTG pathway through an accredited laboratory. Positive adults generally need gastroenterology referral for endoscopy with multiple duodenal biopsies. ESPGHAN permits no-biopsy diagnosis only in children with tTG-IgA at least ten times the assay upper limit and positive EMA-IgA in a second sample, with family agreement and paediatric specialist oversight. Values below that threshold require biopsies including distal duodenum and bulb. High clinical suspicion despite negative serology warrants specialist review.
Differential Diagnosis
Coeliac disease overlaps with many causes of chronic diarrhoea, anaemia, malnutrition and villous injury. Tropical sprue is an important Indian differential, especially with compatible residence or travel, but neither geography nor biopsy appearance alone distinguishes it. Giardiasis, strongyloidiasis and other chronic infections require exposure-sensitive stool or antigen testing. Small-intestinal bacterial overgrowth, pancreatic insufficiency and bile-acid diarrhoea may cause malabsorption. HIV-related enteropathy and intestinal tuberculosis are considered only with supporting clinical and epidemiological evidence, not as reflex labels.
Inflammatory bowel disease, microscopic colitis and eosinophilic or autoimmune enteropathy can mimic symptoms. Crohn disease may involve the small bowel but usually has a different distribution and pathology. Common variable immunodeficiency can cause villous change and recurrent infection; total immunoglobulins and clinical context matter. Medication-related enteropathy, particularly from selected drugs such as olmesartan, can resemble coeliac histology. Pathology should be interpreted with orientation, biopsy site, serology and drug history.
Irritable bowel syndrome and functional bloating are common, but organic warning features and coeliac testing should be addressed before settling on a functional diagnosis. Lactose intolerance may be secondary to active mucosal injury and can improve after healing. Non-coeliac gluten sensitivity is considered only after coeliac disease and wheat allergy have been appropriately excluded; it has no validated diagnostic biomarker. IgE-mediated wheat allergy causes an immediate allergic phenotype and needs allergy assessment rather than a coeliac pathway.
Iron loss from menstruation or gastrointestinal bleeding, thalassaemia trait, nutritional deficiency and parasitic disease may explain anaemia. In a patient already gluten-free, negative antibodies or improving symptoms do not reliably exclude coeliac disease; HLA testing and a supervised gluten challenge may be considered by a specialist.
Management
A confirmed diagnosis leads to lifelong exclusion of wheat, barley and rye. The goal is mucosal recovery, correction of deficiency, normal growth and prevention of complications, not merely short-term relief. Arrange dietetic counselling that covers labels, balanced replacement foods, protein and micronutrient adequacy, cross-contact and the social realities of school, hostels, work, festivals and travel. Naturally gluten-free Indian staples include rice, maize, millets, sorghum, buckwheat, amaranth, pulses, vegetables, fruit, eggs, unprocessed meat and fish; safety still depends on preparation and contamination. Oats should be certified gluten-free and continued only if clinically tolerated.
Map the household kitchen. Separate or thoroughly clean storage bins, sieves, rolling boards, toasters, oil and serving utensils. Loose atta dust, shared chakla-belans, mixed griddles, fried foods, gravies thickened with flour, adulterated besan or spices, sauces, malt and restaurant surfaces can defeat an otherwise careful diet. A gluten-free label and current FSSAI standard should be checked rather than relying on marketing language. Do not prescribe an unnecessarily restrictive dairy-free, low-FODMAP or grain-free diet indefinitely.
At diagnosis, assess and replace proven iron, folate, vitamin B12, vitamin D, calcium or other deficiencies using age-appropriate regimens. Monitor children for catch-up growth and puberty. Review vaccinations and infection risk according to current local policy and individual splenic function; do not automatically import another country's schedule.
Follow-up should be planned rather than symptom-triggered alone. Review symptoms, weight or growth, dietary adherence and serology, and repeat abnormal baseline laboratory tests. Serology trends support follow-up but cannot prove complete absence of gluten. Consider bone-risk assessment and DXA according to age, fracture risk, malnutrition and local guidance. Persistent symptoms require diagnostic re-evaluation, expert diet review and targeted testing before refractory disease is considered.
Prescribing Information
There is no medicine that substitutes for a strict gluten-free diet in uncomplicated coeliac disease. Prescribing focuses on documented deficiency, associated disease and rare specialist-managed complications. Iron replacement should match severity, tolerance, ongoing losses and response; failure of oral iron can reflect continuing mucosal injury, poor adherence, wrong diagnosis or another source of blood loss and should not trigger endless empiricism. Folate and vitamin B12 must be interpreted together when macrocytosis or neurological symptoms are present. Calcium and vitamin D dosing should reflect measured status, age, renal function and total intake.
Review every medicine, supplement and nutraceutical for excipients and reliable manufacturer information when relevant, but avoid claiming that all tablets contain gluten. Unregulated herbal products, protein powders and compounded preparations may have uncertain composition. Patients with diabetes need coordinated dietary adjustment because replacing wheat with refined gluten-free starch can alter carbohydrate intake. Warfarin effect may change as vitamin K absorption and diet stabilize; monitor clinically where applicable.
Dermatitis herpetiformis may respond rapidly to dapsone while the diet takes effect, but treatment belongs with dermatology or an experienced clinician. Check glucose-6-phosphate dehydrogenase status and baseline blood count and liver function, and monitor for haemolysis, methaemoglobinaemia, agranulocytosis, neuropathy and hypersensitivity. Dapsone treats the rash, not the intestinal cause, so the gluten-free diet remains essential.
Corticosteroids or immunosuppressants are not routine coeliac therapy. current guidelines mentions prednisolone as interim symptom treatment for adult refractory disease while specialist advice is awaited, but refractory coeliac disease must first be confirmed. Budesonide, systemic steroids or other agents require specialist phenotype, infection exclusion, nutritional support and malignancy assessment. Never prescribe a gluten challenge casually; its dose, duration and monitoring should be specialist-directed when prior restriction has made diagnosis uncertain.
When to Refer
Refer adults and young people with positive coeliac serology to gastroenterology for confirmation, generally including endoscopy and biopsy. Refer children with positive serology to a paediatric gastroenterologist or paediatrician with relevant expertise; the paediatric no-biopsy pathway is a specialist diagnostic decision, not permission for primary care to label disease from one high titre. Refer despite negative serology when clinical suspicion remains high, particularly with IgA deficiency, inadequate gluten exposure, severe malabsorption or a strong family-risk presentation.
Dietitian referral is central at diagnosis and again when antibodies remain elevated, symptoms persist, nutrition is poor or the household cannot control cross-contact. Paediatric review is needed for faltering growth, delayed puberty or complex dietary restriction. Dermatology referral supports direct-immunofluorescence diagnosis and safe dapsone use for suspected dermatitis herpetiformis. Bone, endocrine, fertility, neurology or haematology input should follow the actual complication rather than a routine package of consultations.
Urgent assessment is needed for severe dehydration, haemodynamic compromise, major gastrointestinal bleeding, profound symptomatic anaemia, acute abdomen or rapidly progressive neurological deficit. New severe abdominal pain, obstruction, persistent fever, unexplained weight loss or a mass in established coeliac disease requires prompt investigation for another diagnosis or a rare complication.
Specialist-centre referral is mandatory when refractory coeliac disease is suspected. Before that label, confirm the original diagnosis, obtain an expert dietetic contamination assessment and investigate common alternatives such as lactose intolerance, IBS, microscopic colitis, infection, pancreatic insufficiency or inflammatory bowel disease. Provide the specialist with original serology, gluten status at testing, endoscopy and pathology reports, laboratory trends, weight trajectory, diet review and current medicines.
Red Flags
Do not explain severe or progressive illness as ordinary dietary contamination. Haematemesis, melaena, major rectal bleeding, shock, peritonism, persistent bilious vomiting, severe dehydration or an acute obstructive picture needs emergency assessment. Marked lethargy, syncope, cardiac symptoms or breathlessness with severe anaemia requires urgent stabilization and investigation. A child with faltering growth, oedema, persistent vomiting, dehydration, developmental regression or delayed puberty needs prompt paediatric evaluation.
In newly suspected disease, significant weight loss, nocturnal diarrhoea, fever, a palpable mass, persistent focal pain, hypoalbuminaemia or inflammatory markers should broaden the differential to inflammatory bowel disease, infection, cancer and other enteropathies. Blood in stool is not a typical feature to dismiss as coeliac disease. Neurological red flags include progressive ataxia, weakness, seizures or cognitive change; assess urgently rather than assuming a gluten-related mechanism.
In established disease, continuing weight loss, anaemia, diarrhoea or pain despite a carefully reviewed gluten-free diet requires renewed confirmation of the original diagnosis and evaluation for ongoing exposure, coexisting conditions and complications. True refractory coeliac disease is rare. Severe pain, obstruction, constitutional symptoms or lymphadenopathy raises concern for ulcerative jejunitis or enteropathy-associated lymphoma and warrants specialist imaging and biopsy planning.
Safeguarding also matters. A child should not be subjected to extreme restriction, school exclusion or repeated invasive testing because of an unconfirmed commercial food panel. Conversely, inability to obtain safe food may reflect poverty rather than non-adherence. Escalate when restrictive practices cause malnutrition, caregiver understanding is inadequate or a vulnerable patient cannot access essential nutrition. Dapsone-related cyanosis, breathlessness, fever, sore throat, rash or neuropathy demands immediate medicine review.
Indian Clinical Context
Indian management must work in kitchens where wheat flour is airborne, utensils are shared and food is frequently purchased loose. Ask who buys, mills and cooks food, not simply whether the patient avoids chapati. Separate sealed flour storage, dedicated sieves and rolling equipment, clean surfaces and oil that has not fried wheat-coated food are practical controls. School meals, hostels, canteens, religious offerings, wedding food, railway travel and restaurant gravies need advance planning. Naturally gluten-free grains can preserve culinary identity and nutrition without depending exclusively on expensive packaged substitutes.
Label interpretation should use the current Food Safety and Standards Authority of India requirements and manufacturer information. A gluten-free claim is not equivalent to a wheat-free claim, and oats require contamination control. Loose besan, spice blends, asafoetida preparations and processed snacks may vary; blanket lists become outdated, so teach a verification method. Dietetic advice must also prevent excessive reliance on polished rice, sugar and ultra-processed gluten-free products.
Testing access is uneven. Ensure the patient is on gluten, request total IgA with tTG-IgA, use a reliable accredited laboratory and retain the assay result with its upper limit of normal. A titre reported without the assay range cannot safely enter a paediatric ten-times-ULN decision. Endoscopy, paediatric gastroenterology, EMA and expert histopathology may require referral to a medical college or tertiary centre. Cost or distance should trigger coordinated referral, not an improvised no-biopsy diagnosis in an adult.
Coeliac disease can coexist with tropical sprue, giardiasis, tuberculosis or nutritional anaemia, but Indian origin is not a diagnostic test for any of them. NMC teaching should integrate clinical reasoning, pathology, immunology, nutrition, community barriers and safe longitudinal care. This organizational review draft does not claim endorsement by an Indian professional body.
NMC Competency Mapping
Coeliac disease fits an integrated competency cluster across paediatrics, general medicine, pathology, biochemistry, pharmacology and community medicine. The learner should recognize both classical malabsorption and non-classical presentations, elicit growth and dietary history, identify family and autoimmune risk, assess nutritional status and construct a differential for chronic diarrhoea, anaemia and villous atrophy. Paediatric malabsorption teaching provides a direct curricular home, while exact code attribution should be verified against the institution's current NMC CBME implementation rather than copied from an older secondary list.
Diagnostic competence includes choosing total IgA plus tTG-IgA while the patient is eating gluten, explaining the IgA-deficiency pathway, interpreting a titre only against its assay upper limit, and knowing why HLA positivity does not confirm disease. Learners should describe appropriate duodenal sampling and recognize Marsh-pattern changes without treating histology in isolation. They must distinguish the selected ESPGHAN paediatric no-biopsy pathway from the usual adult biopsy-confirmation approach and communicate uncertainty when serology and histology disagree.
Management competence includes counselling on lifelong gluten exclusion, identifying Indian sources of gluten and cross-contact, preserving nutritional adequacy, replacing proven deficiency and monitoring growth, weight, serology and bone risk. A case-based assessment can require a practical household diet plan rather than a memorized prohibited-food list. Professional skills include avoiding premature restriction, documenting the gluten status at testing, coordinating dietitian and specialist care, and addressing financial or school barriers without blame.
Assessment should test safety: persistent symptoms prompt review of diagnosis and contamination before immunosuppression; severe weight loss, bleeding, obstruction or progressive neurological features require escalation. Reading this guide supports knowledge and reasoning but does not certify endoscopy, biopsy interpretation or dietetic competence.
Key Exam Pearls for NEET PG
Coeliac disease is an immune-mediated enteropathy triggered by gluten in wheat, barley and rye, strongly associated with HLA-DQ2 or DQ8. HLA negativity is useful to make disease very unlikely in selected uncertain cases; HLA positivity is common and does not diagnose it. Presentations include chronic diarrhoea and growth failure, but iron-deficiency anaemia, low bone density, aphthae, dermatitis herpetiformis, transaminitis, neuropathy and infertility are high-yield non-classical clues.
Test during gluten exposure. The first-line pair is tTG-IgA plus total IgA. In IgA deficiency, use an appropriate IgG-based coeliac test. EMA can clarify or confirm selected results. A negative antibody does not end evaluation when gluten intake was inadequate, IgA was not assessed or clinical suspicion remains high. Do not diagnose from symptom response to a gluten-free diet, an isolated HLA result or a commercial intolerance panel.
Most adults require upper endoscopy with multiple biopsies from the duodenal bulb and distal duodenum. In children, ESPGHAN permits a biopsy-free diagnosis only through specialist care when tTG-IgA is at least ten times the assay upper limit and EMA-IgA is positive in a second blood sample; lower titres require biopsy. This paediatric rule should never be casually extrapolated to adults or IgA-deficient patients.
Treatment is a strict lifelong gluten-free diet with expert nutritional support. Monitor symptoms, growth or weight, serology, baseline deficiencies and bone risk. Persistent symptoms most commonly call for confirmation of diagnosis, contamination review and alternative diagnoses; refractory disease is rare and specialist-managed. Dermatitis herpetiformis may need dapsone for symptoms, but diet treats the underlying disease. In India, remember contaminated flour, shared utensils and tropical sprue or giardiasis in the differential without stereotyping.
Frequently Asked Questions
Should a patient stop gluten before coeliac blood tests or endoscopy?
No. Coeliac antibodies and mucosal injury can fall after gluten withdrawal, creating falsely reassuring tests and a difficult future gluten challenge. While diagnosis is being pursued, the patient should continue a gluten-containing diet unless a specialist gives a different plan. Current guidelines advises gluten in more than one meal daily for at least six weeks when a normal gluten-containing diet has not been maintained. A patient who is already gluten-free, is medically unable to reintroduce gluten or refuses after informed discussion should be referred; HLA testing and a supervised challenge may help selected cases, but neither symptoms nor HLA positivity alone confirms disease.
Can coeliac disease be diagnosed without a duodenal biopsy?
Sometimes in children, but only under a tightly defined paediatric specialist pathway. ESPGHAN requires tTG-IgA at least ten times the assay upper limit and positive EMA-IgA in a second blood sample, with family agreement and specialist oversight. Children below that antibody threshold need appropriately sampled duodenal biopsies. Most adults still require biopsy confirmation because a lifelong restrictive diagnosis has major medical and social consequences and other conditions can mimic serology or histology. The rule cannot be applied when the laboratory range is unknown, the child is IgA deficient, gluten intake is inadequate or the clinical and laboratory findings are discordant.
Why can a coeliac screen be negative in someone who still has the disease?
The commonest preventable reasons are testing after gluten restriction and ordering tTG-IgA without checking total IgA. Selective IgA deficiency can make an IgA-only result falsely negative and requires an IgG-based pathway. Test performance also depends on assay quality, age and disease burden. If symptoms, malnutrition, family risk or another clinical clue keeps suspicion high, specialist assessment is appropriate despite negative serology. The clinician should verify the actual gluten intake, assay and reference range, consider alternative diagnoses and decide whether endoscopy, HLA testing or a supervised gluten challenge is justified rather than repeating the same incomplete panel.
What should be checked when symptoms continue despite a gluten-free diet?
First confirm that the original diagnosis was secure and arrange a detailed review with a coeliac-trained dietitian. Hidden exposure may come from shared flour, utensils, frying oil, oats, restaurant gravies, loose ingredients, supplements or medicines. Serology trends help but cannot prove complete exclusion. Investigate the symptom pattern for lactose intolerance, irritable bowel syndrome, microscopic colitis, inflammatory bowel disease, infection, pancreatic insufficiency or another enteropathy, and repeat baseline deficiency tests when indicated. Persistently high antibodies, weight loss, anaemia or ongoing villous injury may require repeat endoscopy. Refractory coeliac disease is rare and should be diagnosed and treated only in a specialist centre after gluten exposure and coexisting disease are excluded.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic